AngioDynamics Statistics
Total Valuation
AngioDynamics has a market cap or net worth of $383.74 million. The enterprise value is $349.67 million.
Important Dates
The next estimated earnings date is Tuesday, July 15, 2025, before market open.
| Earnings Date | Jul 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AngioDynamics has 40.61 million shares outstanding. The number of shares has increased by 1.84% in one year.
| Current Share Class | 40.61M |
| Shares Outstanding | 40.61M |
| Shares Change (YoY) | +1.84% |
| Shares Change (QoQ) | -0.17% |
| Owned by Insiders (%) | 6.44% |
| Owned by Institutions (%) | 84.94% |
| Float | 35.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.36 |
| Forward PS | 1.27 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 3.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.21 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -20.46% and return on invested capital (ROIC) is -9.54%.
| Return on Equity (ROE) | -20.46% |
| Return on Assets (ROA) | -6.55% |
| Return on Invested Capital (ROIC) | -9.54% |
| Return on Capital Employed (ROCE) | -15.42% |
| Revenue Per Employee | $378,770 |
| Profits Per Employee | -$55,337 |
| Employee Count | 748 |
| Asset Turnover | 0.93 |
| Inventory Turnover | 2.13 |
Taxes
| Income Tax | -671,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.53% in the last 52 weeks. The beta is 0.58, so AngioDynamics's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | +49.53% |
| 50-Day Moving Average | 9.47 |
| 200-Day Moving Average | 8.72 |
| Relative Strength Index (RSI) | 51.18 |
| Average Volume (20 Days) | 317,379 |
Short Selling Information
The latest short interest is 1.49 million, so 3.68% of the outstanding shares have been sold short.
| Short Interest | 1.49M |
| Short Previous Month | 1.70M |
| Short % of Shares Out | 3.68% |
| Short % of Float | 4.16% |
| Short Ratio (days to cover) | 2.58 |
Income Statement
In the last 12 months, AngioDynamics had revenue of $283.32 million and -$41.39 million in losses. Loss per share was -$1.02.
| Revenue | 283.32M |
| Gross Profit | 154.00M |
| Operating Income | -31.99M |
| Pretax Income | -191.64M |
| Net Income | -41.39M |
| EBITDA | -7.61M |
| EBIT | -31.99M |
| Loss Per Share | -$1.02 |
Full Income StatementBalance Sheet
The company has $44.76 million in cash and $10.70 million in debt, giving a net cash position of $34.06 million or $0.84 per share.
| Cash & Cash Equivalents | 44.76M |
| Total Debt | 10.70M |
| Net Cash | 34.06M |
| Net Cash Per Share | $0.84 |
| Equity (Book Value) | 185.87M |
| Book Value Per Share | 4.54 |
| Working Capital | 94.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$23.94 million and capital expenditures -$4.25 million, giving a free cash flow of -$28.19 million.
| Operating Cash Flow | -23.94M |
| Capital Expenditures | -4.25M |
| Free Cash Flow | -28.19M |
| FCF Per Share | -$0.69 |
Full Cash Flow StatementMargins
Gross margin is 54.36%, with operating and profit margins of -11.29% and -14.61%.
| Gross Margin | 54.36% |
| Operating Margin | -11.29% |
| Pretax Margin | -14.85% |
| Profit Margin | -14.61% |
| EBITDA Margin | -2.69% |
| EBIT Margin | -11.29% |
| FCF Margin | n/a |
Dividends & Yields
AngioDynamics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.84% |
| Shareholder Yield | -1.84% |
| Earnings Yield | -10.79% |
| FCF Yield | -7.35% |
Analyst Forecast
The average price target for AngioDynamics is $14.00, which is 48.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 48.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 5.48% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AngioDynamics has an Altman Z-Score of 0.76 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.76 |
| Piotroski F-Score | 3 |